DrugPatentWatch Database Preview

Plecanatide - Generic Drug Details

« Back to Dashboard

What are the generic sources for plecanatide and what is the scope of plecanatide freedom to operate?

Plecanatide is the generic ingredient in one branded drug marketed by Synergy Pharms and is included in one NDA. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Plecanatide has fifty-three patent family members in fourteen countries.

One supplier is listed for this compound.

Summary for plecanatide

International Patents:	53
US Patents:	8
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	3
Clinical Trials:	10
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for plecanatide
DailyMed Link:	plecanatide at DailyMed

Pharmacology for plecanatide

Drug Class	Guanylate Cyclase-C Agonist
Mechanism of Action	Guanylate Cyclase Activators

Synonyms for plecanatide

(3-Glutamic acid(D>E))human uroguanylin (UGN)

[3-glutamic acid(D>E)]human uroguanylin

467426-54-6

7IK8Z952OK

CHEMBL2103867

DB13170

DTXSID60196933

GTPL9069

Guanilib

Plecanatide [USAN:INN]

SP-304

Trulance

UNII-7IK8Z952OK

US Patents and Regulatory Information for plecanatide

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes
Synergy Pharms	TRULANCE	plecanatide	TABLET;ORAL	208745-001	Jan 19, 2017		RX	Yes	Yes

International Patents for plecanatide

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2012037380
Germany	60233040
European Patent Office	2944648